UBS Group AG - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 23 filers reported holding BIOPHARMX CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2019$3,000
+200.0%
38,029
+815.3%
0.00%
Q3 2018$1,000
-50.0%
4,155
-62.4%
0.00%
Q2 2018$2,000
-87.5%
11,051
-84.3%
0.00%
Q1 2018$16,000
+300.0%
70,367
+108.5%
0.00%
Q4 2017$4,000
+33.3%
33,753
+207.9%
0.00%
Q3 2017$3,000
+50.0%
10,961
+116.4%
0.00%
Q2 2017$2,000
-33.3%
5,064
-29.1%
0.00%
Q4 2016$3,000
-25.0%
7,147
-8.8%
0.00%
Q3 2016$4,000
-42.9%
7,839
-25.2%
0.00%
Q2 2016$7,000
+250.0%
10,484
+753.7%
0.00%
Q4 2015$2,000
-90.0%
1,228
-93.6%
0.00%
Q3 2015$20,000
+566.7%
19,264
+1826.4%
0.00%
Q2 2015$3,0001,0000.00%
Other shareholders
BIOPHARMX CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 16,128,515$1,740,0000.22%
FRG Family Wealth Advisors LLC 30,000$3,0000.00%
LEVEL FOUR ADVISORY SERVICES, LLC 66,933$7,0000.00%
Chicago Partners Investment Group LLC 32,462$4,0000.00%
Virtu Financial LLC 98,004$11,0000.00%
NORTHERN TRUST CORP 92,518$10,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 1,343,372$144,0000.00%
MILLENNIUM MANAGEMENT LLC 25,349$3,0000.00%
OPPENHEIMER & CO INC 25,000$3,0000.00%
View complete list of BIOPHARMX CORP shareholders